All Stories

  1. Prediction of New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction: A Machine Learning Approach
  2. Advanced Pulmonary Drug Delivery Systems: A Narrative Review
  3. Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  4. Global, regional, and national burden of exposure to chewing tobacco, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023
  5. Gender disparities in heart failure diagnosis and management: under the radar
  6. Prediction of New Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction Using Artificial Intelligence and Machine Learning Algorithms
  7. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  8. How type 2 diabetes and COPD affect each other: a review of mechanisms and patient management
  9. COPD Trial Evidence Comes from a Narrow Slice of the World: A Population Representativeness Analysis.
  10. Kounis Syndrome Features in Special Populations
  11. Impact of older age on prognosis in hypersensitivity pneumonitis: A systematic review and meta‑analysis
  12. COPD and kidney disease: not so far apart?
  13. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  14. A deep dive into atrial fibrillation in chronic obstructive pulmonary disease
  15. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  16. Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
  17. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
  18. Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis
  19. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  20. Patients with sickle cell disease and asthma have a higher risk for acute chest syndrome: A systematic review and meta‑analysis of observational studies
  21. Impact of urogenital and enterocolitic infections on the onset and evolution of ankylosing spondylitis and psoriatic arthritis
  22. Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions
  23. The Hidden Burden of COMISA: Clinical Implications and Treatment Challenges
  24. Burden of ophthalmologic disorders in obstructive sleep apnea
  25. Diagnostic and management controversies in ANCA-associated interstitial lung diseases
  26. Fungal allergy - features of molecular diagnosis
  27. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease
  28. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  29. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  30. Diagnostic challenges in differentiating pulmonary sarcoidosis from tuberculosis: the role of QuantiFERON TB Gold in an endemic region
  31. Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review)
  32. The impact of comorbidities on chronic obstructive pulmonary disease
  33. Tuberculosis in new cases: the impact of HIV status on clinical manifestations
  34. Comparative analysis of clinical characteristics of gout patients
  35. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
  36. Anti-reflux therapy and mortality in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a systematic review and meta-analysis
  37. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders—Part II
  38. Diurnal variation in spirometry parameters of patients with chronic obstructive pulmonary disease: A systematic review and meta‑analysis
  39. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  40. Metabolic storm in psoriatic arthritis: a cardiovascular time bomb?
  41. Diagnostic tools in respiratory medicine (Review)
  42. COPD and Depression—The Vicious Mental Cycle
  43. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  44. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  45. Challenges of Pediatric Tuberculosis Under Current Conditions
  46. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  47. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  48. Assessment of comorbidities in COPD patients by chest HRCT
  49. Endobronchial foreign bodies in pediatric work – history and clinical signs suggestive of diagnosis
  50. Sarcoidosis and cancer - a diagnostic dilema
  51. Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
  52. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  53. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  54. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  55. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  56. Editorial: Treatment of comorbidities of asthma and its safety
  57. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  58. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  59. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  60. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  61. Promising treatment biomarkers in asthma
  62. Complications of tracheobronchial foreign body aspiration in children
  63. Phenotypes in adult patients with bronchiectasis: a cluster analysis
  64. The Burden of Comorbidities in Obstructive Sleep Apnea
  65. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  66. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  67. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  68. Updates in screening for tuberculosis. Review of guidelines
  69. Diagnostic challenges of a rare disease with an unusual presentation
  70. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  71. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  72. COPD and Diabetes Mellitus: Down the Rabbit Hole
  73. Scientists Against War: A Plea to World Leaders for Better Governance
  74. COPD and comorbidities in the Republic of Moldova
  75. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  76. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  77. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  78. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  79. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  80. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  81. Asthma-COPD Overlap: A more Simplistic Approach
  82. Chronic obstructive disease and comorbidities (literature review)
  83. Current Approaches to Asthma In 2021
  84. A rare case of intrathymic epidermoid cyst
  85. Asthma and stroke: a narrative review
  86. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  87. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  88. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  89. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  90. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  91. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  92. Current Approaches to COPD in 2019
  93. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  94. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  95. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  96. Identification of clinical phenotypes using cluster analyses in COPD patients
  97. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  98. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  99. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  100. COPD and Stroke
  101. Health-related quality of life in different phenotypes of COPD
  102. Assessment of health-related quality of life in different phenotypes of COPD
  103. Bode index in different phenotypes of COPD
  104. To sleep, or not to sleep?
  105. ACOS: current evidence and future research directions
  106. Phenotyping Before Starting Treatment in COPD?
  107. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  108. Exercise-Induced Pulmonary Edema in Athletes
  109. Editorial: "COPD: More than a Moving Target!"
  110. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  111. Prevalence and burden of comorbidities in COPD
  112. Meet Our Assistant Editor
  113. Overview of the translocation of rupestrian ferruginous fields of Capão Xavier mine to the Serra do Rola Moça State Park, Minas Gerais – Brazil
  114. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  115. Health-Related Quality of Life in Patients with COPD
  116. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  117. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  118. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  119. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  120. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  121. Management of Stable COPD: An Update
  122. Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report
  123. Defining COPD
  124. Imaging for diagnosis and management of tuberculosis